白癜风样小鼠皮肤脱色模型研究进展与思考[14]

［4］ Kunisada T, Lu SZ, Yoshida H, et al. Murine cutaneousmastocytosis and epidermal melanocytosis induced bykeratinocyte expression of transgenic stem cell factor［J］. J ExpMed, 1998,187（10）:1565⁃1573. doi: 10.1084/jem.187.10.1565.

［5］ Ito S, Okura M, Nakanishi Y, et al. Tyrosinase ⁃ catalyzedmetabolism of rhododendrol （RD） in B16 melanoma cells:production of RD ⁃ pheomelanin and covalent binding with thiolproteins［J］. Pigment Cell Melanoma Res, 2015,28（3）:295⁃306.doi: 10.1111/pcmr.12363.

［6］ Hayashi M, Okamura K, Abe Y, et al. Janus kinase inhibitortofacitinib does not facilitate the repigmentation in mouse modelof rhododendrol ⁃ induced vitiligo［J］. J Dermatol, 2019,46（6）:548⁃550. doi: 10.1111/1346⁃8138.14879.

［7］ Tsutsumi R, Sugita K, Abe Y, et al. Leukoderma induced byrhododendrol is different from leukoderma of vitiligo inpathogenesis: a novel comparative morphological study［J］. JCutan Pathol, 2019,46（2）:123⁃129. doi: 10.1111/cup.13396.